🔗 Share this article

This year's Nobel Prize in medical science has been awarded for revolutionary discoveries that illuminate how the body's defense network attacks harmful pathogens while protecting the healthy tissues.

A trio of esteemed researchers—from Japan Shimon Sakaguchi and US scientists Mary Brunkow and Dr. Ramsdell—share this honor.

Their research identified specialized "sentinels" within the immune system that eliminate malfunctioning defense cells capable of attacking the body.

These findings are now enabling new treatments for immune disorders and cancer.

The winners will divide a monetary award valued at 11 million SEK.

Crucial Findings

"Their research has been essential for comprehending how the body's defenses operates and why we don't all suffer from severe self-attack conditions," stated the chair of the Nobel Committee.

This team's research address a core mystery: In what way does the defense system defend us from numerous infections while leaving our own tissues unharmed?

The body's protection system employs immune cells that scan for indicators of infection, even pathogens and germs it has never encountered.

Such cells utilize sensors—called recognition units—that are generated randomly in a vast number of combinations.

That gives the defense network the capacity to combat a wide array of invaders, but the unpredictability of the process unavoidably produces white blood cells that may target the host.

Protectors of the Immune System

Researchers previously understood that some of these harmful white blood cells were eliminated in the thymus—where immune cells mature.

This year's award honors the discovery of T-reg cells—described as the body's "security guards"—which patrol the system to neutralize any immune cells that assault the healthy cells.

We know that this process malfunctions in autoimmune diseases such as juvenile diabetes, MS, and rheumatoid arthritis.

A Nobel panel stated, "These findings have established a novel area of research and spurred the development of new therapies, for instance for cancer and immune disorders."

Regarding cancer, regulatory T-cells prevent the system from attacking the growth, so studies are focused on reducing their quantity.

For autoimmune diseases, trials are exploring boosting regulatory T-cells so the organism is no longer being harmed. A comparable approach could also be useful in minimizing the chances of organ transplant failure.

Innovative Experiments

Professor Sakaguchi, from Osaka University, performed tests on mice that had their thymus extracted, leading to self-attack conditions.

The researcher demonstrated that introducing immune cells from other animals could prevent the illness—implying there was a mechanism for preventing immune cells from harming the host.

Mary Brunkow, affiliated with the a research center in Seattle, and Fred Ramsdell, now at a biotech firm in a California city, were studying an inherited immune disorder in rodents and people that resulted in the identification of a genetic factor critical for the way T-regs function.

"Their groundbreaking work has uncovered how the body's defenses is kept in check by T-reg cells, stopping it from mistakenly targeting the body's own tissues," commented a prominent physiology specialist.

"This research is a remarkable example of how fundamental biological research can have far-reaching consequences for public health."